Terms: = Lung cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Prognosis
11 results:
1. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
[TBL] [Abstract] [Full Text] [Related]
2. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven lung Tumorigenesis.
Vaishnavi A; Juan J; Jacob M; Stehn C; Gardner EE; Scherzer MT; Schuman S; Van Veen JE; Murphy B; Hackett CS; Dupuy AJ; Chmura SA; van der Weyden L; Newberg JY; Liu A; Mann K; Rust AG; Weiss WA; Kinsey CG; Adams DJ; Grossmann A; Mann MB; McMahon M
Cancer Res; 2022 Nov; 82(22):4261-4273. PubMed ID: 36112789
[TBL] [Abstract] [Full Text] [Related]
3. Methylation analysis of APC, axin2, DACT1, RASSF1A and MGMT gene promoters in non-small cell lung cancer.
Paschidis K; Zougros A; Chatziandreou I; Tsikalakis S; Korkolopoulou P; Kavantzas N; Saetta AA
Pathol Res Pract; 2022 Jun; 234():153899. PubMed ID: 35489124
[TBL] [Abstract] [Full Text] [Related]
4. Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing.
Zhang H; Jiang D; Jin H; Cui YZ; Wei SJ; Li Y; Dong Q; Zuo J; Tian CJ; Yan F; Wang XW
Neoplasma; 2022 Mar; 69(2):352-360. PubMed ID: 35081725
[TBL] [Abstract] [Full Text] [Related]
5. Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell lung cancer.
Yu JE; Ju JA; Musacchio N; Mathias TJ; Vitolo MI
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302540
[TBL] [Abstract] [Full Text] [Related]
6. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Variants in the Wingless Antagonist Genes (
Bahl C; Singh N; Behera D; Sharma S
Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
[No Abstract] [Full Text] [Related]
8. Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Tong Y; Liu Y; Zheng H; Zheng L; Liu W; Wu J; Ou R; Zhang G; Li F; Hu M; Liu Z; Lu L
Oncotarget; 2016 May; 7(21):31413-28. PubMed ID: 27119499
[TBL] [Abstract] [Full Text] [Related]
9. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.
Stewart DJ; Chang DW; Ye Y; Spitz M; Lu C; Shu X; Wampfler JA; Marks RS; Garces YI; Yang P; Wu X
Pharmacogenomics J; 2014 Dec; 14(6):509-22. PubMed ID: 24980784
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
[TBL] [Abstract] [Full Text] [Related]
11. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Albring KF; Huber O; Petersen I
Carcinogenesis; 2012 Oct; 33(10):1863-70. PubMed ID: 22791817
[TBL] [Abstract] [Full Text] [Related]